ArticlePloS one2021

Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results".

Axel C Mühlbacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.